BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 7, 2004
View Archived Issues
Bevacizumab reported to increase antitumor effects of FOLFOX4 chemotherapy in colorectal cancer
Read More
Citrus bioflavonoid naringin and lovastatin show comparable hypocholesterolemic effects in vivo
Read More
Phase I data suggest a favorable safety profile for APD-356 in obese subjects
Read More
HuMax-EGFr shows promise in the treatment of head and neck cancer
Read More
Garlic derivative may attenuate intestinal inflammation
Read More
EP-2306 and EP-2302 effectively inhibit LDL oxidation, possible application in atherosclerosis
Read More
p38 kinase inhibitors claimed in three GlaxoSmithKline patents
Read More
Fournier prepares and tests new bradykinin B1 antagonists for treatment of pain
Read More
Pfizer presents novel antibacterial oxazolidinones
Read More
Researchers at Dynogen describe a new treatment for urinary tract disorders
Read More
Putative metabolites of rosiglitazone described in a patent
Read More
Scientists at Merck describe novel series of serotonin antagonists
Read More
New RXR antagonists in early development at Novartis for diabetes and diabetic complications
Read More
KXS-01: novel antiangiogenic agent prevents endothelial cell proliferation and migration in vitro
Read More
LXT-101, a novel GnRH antagonist, potently reduces testosterone levels in male rats
Read More
Icatibant induces pain relief in patients with osteoarthritis of the knee
Read More
Lumiracoxib reported as effective as celecoxib in OA of the knee
Read More
Imatinib shows activity in AIDS-related Kaposi's sarcoma
Read More
Certican approval extended to new E.U. member states
Read More
ODAC votes against recommending approval of Marqibo
Read More
NovaCal IND cleared for phase II trials of NVC-101
Read More
Fast track designation for CG-53135 for prevention of oral mucositis
Read More
New data on mechanism of action of PCK-3145
Read More
Allon Therapeutics reviews Q3 highlights
Read More
Medical Discoveries files IND for phase I cystic fibrosis study of MDI-P
Read More
Kyorin to acquire ActivX Biosciences
Read More
Launch of Fuzeon Accelerated Simultaneous Access Program
Read More
Guilford to acquire ProQuest
Read More
Low-dose PW-2101 fails to meet primary endpoint in pivotal hypertension study
Read More